After-Hours Stock Movers 09/13: (THC) (UNFI) (PCYG) Higher; (ARRY) (VNDA) (EPZM) Lower (more...)
Today's After-Hours Movers
Tenet Healthcare (NYSE: THC) 12% HIGHER; is exploring strategic options including a sale after facing activist pressure, according to the Wall Street Journal, citing people familiar with the matter. The company hired advisers to look at a range of options.
Array BioPharma Inc. (NASDAQ: ARRY) 8.8% LOWER; today announced that it has commenced an underwritten public offering of $175,000,000 of shares of its common stock. Array BioPharma also intends to grant the underwriters a 30-day option to purchase up to an additional $26,250,000 of shares of its common stock offered in the public offering. All of the shares in the offering are to be sold by Array BioPharma.
United Natural Foods (NASDAQ: UNFI) 6.7% HIGHER; reported Q4 EPS of $0.72, $0.02 better than the analyst estimate of $0.70. Revenue for the quarter came in at $2.34 billion versus the consensus estimate of $2.36 billion. GUIDANCE: United Natural Foods sees FY2018 EPS of $2.67-$2.77, versus the consensus of $2.67. United Natural Foods sees FY2018 revenue of $9.63-9.81 billion, versus the consensus of $9.75 billion.
Park City Group (NASDAQ: PCYG) 5.5% HIGHER; reported Q4 EPS of $0.05. Revenue for the quarter came in at $5.2 million.
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) 5% LOWER; announced results from an 8-week randomized Phase II clinical study of tradipitant as a monotherapy in the treatment of chronic pruritus in patients with atopic dermatitis. Tradipitant was shown to improve the intensity of the worst itch patients experienced, as well as atopic dermatitis disease severity.
Lakeland Industries (NASDAQ: LAKE) 4.4% HIGHER; reported Q2 EPS of $0.25, $0.05 better than the analyst estimate of $0.20. Revenue for the quarter came in at $23.9 million versus the consensus estimate of $23.91 million.
Epizyme, Inc. (NASDAQ: EPZM) 4% LOWER; announced that it intends to offer and sell $120 million of shares of its common stock in an underwritten public offering. Epizyme also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock offered in the public offering. All of the shares in the proposed offering are to be sold by Epizyme.
US Foods Holding Corp. (NYSE: USFD) 2.7% LOWER; announced an offering of an aggregate of 40,000,000 shares of its common stock by investment funds associated with Clayton, Dubilier & Rice, LLC and Kohlberg Kravis Roberts & Co. L.P. (collectively, the “Selling Stockholders”). In connection with the offering, the Selling Stockholders will grant to the underwriters a 30-day option to purchase up to an additional 6,000,000 shares of common stock.
Lattice Semiconductor (Nasdaq: LSCC) 1.6% LOWER; President Trump blocked a Chinese-backed investor from buying Lattice on national-security ris
William Lyon Homes (NYSE: WLH) 1.3% LOWER; announced that an entity affiliated with Paulson & Co. Inc. (“Seller”) intends to offer 3,322,666 shares of the Company’s Class A Common Stock in a registered public offering. The Company will not sell any shares in this offering or receive any portion of the proceeds from this offering.